Jointly provided by the National Hemophilia Foundation, Impact Education, LLC and Medical Education Resources, Inc.
|
This activity is supported by an independent educational grant from Shire, now part of Takeda.
|
Monday, March 25, 2019
6:00 PM - 8:00 PM
Marriott Marquis San Diego Marina
Room: Marina Ballroom F&G (South Tower-Level 3)
San Diego, CA
*Immediately following the Specialty Connect
Please note: No additional fee is required to attend this CME/CPE activity; however, registration to the AMCP Managed Care & Specialty Pharmacy Annual Meeting 2019 is required.
|
|
Click here to download the slides from this symposium.
If you attended this symposium and need to complete an evaluation or claim credit, click here. Use code 2519. Be sure to follow the instructions to claim credit after submitting your evaluation.
|
|
Hot Topics
|
- Expert insights on recently approved and emerging hemophilia treatment options
- Clinical and economic impact of inhibitor development
- Hemophilia treatment centers (HTCs) overview and application of the comprehensive care model
- Update on the National Hemophilia Foundation's collaborative payer/provider initiatives
|
Expert Faculty Presenters
|
|
|
|
|
Edmund Pezalla, MD, MPH
CEO
Enlightenment Bioconsult, LLC
|
|
Shannon Carpenter, MD, MS
Professor of Pediatrics, UMKC School of Medicine
Hematology/Oncology, Director Kansas City Regional Hemophilia Treatment Center
Director, Anticoagulation Management Program
Children's Mercy Hospital
|
|
Jeffrey Dunn, PharmD, MBA
Vice President, Clinical Strategy and Programs and Industry Relations
Magellan Rx Management
|
|
|
|
Who Should Attend?
|
This activity is designed to meet the educational needs of managed care pharmacy directors, clinical pharmacists, quality directors, medical directors, members of the AMCP, and other managed health care professionals attending the AMCP 2019 Managed Care and Specialty Pharmacy Annual Meeting.
|
|
Statement of Need/Program Overview
|
The management of hemophilia is complex; however, appropriate management is vital to minimizing and/or preventing complications that can contribute to poorer health outcomes and higher health care resource utilization. Thus, there is a need for continued education in several key areas involving the effective management of patients with hemophilia in managed care and specialty pharmacy settings. The multidisciplinary faculty panel will emphasize the need for a well-coordinated patient management effort, the importance of understanding the most cost-effective ways of using available treatments, and the importance of collaboration among all stakeholders, which includes leveraging the success of the comprehensive care model utilized by HTCs.
|
|
Educational Objectives
|
At the conclusion of this activity, participants should be able to demonstrate improved ability to:
- Describe recent insights into the safety, efficacy, and attributes of recently approved and emerging hemophilia treatment options
- Review alignment of recently approved therapies in the current hemophilia treatment algorithm
- Explain hemophilia-related complications associated with inhibitor development and its significant clinical and economic consequences
- Apply processes for managed care and specialty pharmacy professionals to improve communications and collaborations with HTCs
|
|
Agenda
|
Date and Time
Monday, March 25, 2019
6:00 PM - 8:00 PM
Marriott Marquis San Diego Marina
Room: Marina Ballroom F&G (South Tower-Level 3)
San Diego, CA
|
|
6:00 PM
|
Pre-Activity Learning Assessment and Opening Comments/Overview
Edmund Pezalla, MD, MPH
|
|
6:05 PM
|
Assessing the Clinical Benefits and Appropriate Use of Current and Emerging Hemophilia Treatment Options
Shannon Carpenter, MD, MS
|
|
6:45 PM
|
Medical and Pharmacy Benefit Management Strategies for Cost Effective Hemophilia Care
Edmund Pezalla, MD, MPH
|
|
7:15 PM
|
Hemophilia Treatment Center Care Coordination and Communication Strategies to Enhance Patient Outcomes
Jeffrey Dunn, PharmD, MBA
|
|
7:40 PM
|
Audience Q&A Session
|
|
7:55 PM
|
Key Takeaways and Closing Comments; Post-Activity Assessment and Evaluation
|
|
8:00 PM
|
Adjournment
|
|
Physician Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Medical Education Resources, Inc. (MER), the National Hemophilia Foundation and Impact Education, LLC. MER is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
Medical Education Resources, Inc. designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacy Credit
 |
Medical Education Resources, Inc. (MER) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. MER designates this continuing education activity for 2.0 contact hours (0.20 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number: 0816-9999-19-098-L01-P
This activity is certified as Knowledge-based CPE.
|
Disclosure of Conflicts of Interest
It is the policy of Medical Education Resources, Inc. to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis.
Americans with Disabilities Act
♿ Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Impact Education, LLC, prior to the live event at (215) 619-8812.
Fee Information
No additional fee is required to attend this CME/CPE activity.
Please note: No additional fee is required to attend this CME/CPE activity; however, registration to the AMCP Managed Care & Specialty Pharmacy Annual Meeting 2019 is required.
Pre-registration will close at 12:00 pm on March 24, 2019.
Walk-in registration will be available at the time of the program.
If you have any questions, please call (215) 619-8812 or email info@impactedu.net.
|
|
.jpg)